Skip to main content
Fig. 8 | BMC Surgery

Fig. 8

From: The impact of an open-label design on human amniotic membranes vs. silver sulfadiazine dressings for second-degree burns: a randomized controlled clinical trial

Fig. 8

The patients’ wound who have been treated with human amniotic membrane and silver sulfadiazine. (A) Second-degree burn wound on the edge of the right foot on the first day have been treated with human amniotic membrane. (B) Second-degree burn wound on the edge of the right foot on day 7 have been treated with human amniotic membrane. The amniotic membrane gradually peels off the skin as the wound heals, leaving a smooth and scarless surface. (C) Second-degree burn wound on the edge of the right foot on day 30 have been treated with human amniotic membrane

Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us